Hiroto Tanaka
About
In The Last Decade
Hiroto Tanaka
28 papers receiving 369 citations
Peers
Comparison fields: 5 of 75
- Oncology 106
- Epidemiology 100
- Hepatology 100
- Immunology 96
- Molecular Biology 69
Countries citing papers authored by Hiroto Tanaka
This map shows the geographic impact of Hiroto Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroto Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroto Tanaka more than expected).
Fields of papers citing papers by Hiroto Tanaka
This network shows the impact of papers produced by Hiroto Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroto Tanaka. The network helps show where Hiroto Tanaka may publish in the future.
Co-authorship network of co-authors of Hiroto Tanaka
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroto Tanaka. A scholar is included among the top collaborators of Hiroto Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroto Tanaka. Hiroto Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 18 | |
| 7 | 20 | |
| 8 | A new method for rapid cytotoxic T-lymphocyte induction using a multiple cytokine cocktail. | 4 |
| 9 | 42 | |
| 10 | Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro. | 31 |
| 11 | 12 | |
| 12 | 9 | |
| 13 | 5 | |
| 14 | Reduction of regional cerebral blood flow of patients with liver cirrhosis and its correlation with serum albumin | 1 |
| 15 | 12 | |
| 16 | 8 | |
| 17 | 2 | |
| 18 | 30 | |
| 19 | 2 | |
| 20 | Serum immunoglobulin and complement C3 levels in workers exposed to lead. | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.